Abstract
Cryoablation is a minimally invasive treatment option that utilizes cryogens to apply freezing temperatures and destroy target tissues. It may be used as a primary treatment for localized tumors or as a palliative therapy for large or painful tumors. Improvements in image guidance allowing for real-time monitoring and improvements in cryoablative equipment with enhanced freezing capacity and smaller diameter cryoapplicators are fostering the continued development of this well-tolerated treatment in many clinical settings.
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsReferences
Baust JG, Gage AA, Robilotto AT, Baust JM. The pathophysiology of thermoablation: optimizing cryoablation. Curr Opin Urol. 2009;19(2):127–32.
Cooper SM, Dawber RPR. The history of cryosurgery. JR Soc Med. 2001;94(4):196–201.
Beland MD, Dupuy DE, Mayo-Smith WW. Percutaneous cryoablation of symptomatic extraabdominal metastatic disease: preliminary results. AJR Am J Roentgenol. 2005;184:926–30.
Arnott J. On the treatment of cancer by the regulated application of an anaesthetic temperature. London: Churchill; 1851.
Cooper IS. Cryogenic surgery: a new method of deconstruction or extirpation of benign or malignant tissues. N Eng J Med. 1963;268:743–9.
Gonder M, Sloanes W, Smith V. Experimental prostate cryosurgery. Invest Urol. 1964;1:610–9.
Bush IM, Santoni E, Lieberman PH, Cahan WG, Whitmore WF. Some effects of freezing the rat kidney in situ. Cryobiology. 1964;2:163–70.
Gage AA. History of cryosurgery. Semin Surg Oncol. 1998;14:99–109.
Gage AA, Baust JG. Cryosurgery for tumors. J Am Coll Surg. 2007;205(2):342–56.
Baust JG, Gage AA. The molecular basis of cryosurgery. BJU Int. 2005;95:1187–91.
Baust JG, Gage AA, Clarke D, Baust JM, Van Buskirk R. Cryosurgery – a putative approach to molecular-based optimization. Cryobiology. 2004;48:190–204.
Carvalhal EF, Novick AC, Gill IS. Renal cryoablation application in nephron-sparing treatment. Braz J Urol. 2000;26:558–70.
Clarke D, Hollister WR, Baust JG, van Buskirk RG. Cryosurgical modeling: sequence of freezing and cytotoxic agent application affects cell death. Mol Urol. 1999;3:25–31.
Klossner DP, Clarke DM, VanBuskirk RG, et al. Cryosurgical technique: assessment of the fundamental variables using human prostate cancer model systems. Cryobiology. 2007;55:189–99.
Gage AA, Baust JG. Mechanisms of tissue injury in cryosurgery. Cryobiology. 1998;37:171–86.
Cohen J, Miller R, Shuman B. Urethral warming catheter for use during cryoablation of the prostate. Urology. 1995;45:861–4.
Yang WL, Addona T, Nair DG, et al. Apoptosis induced by cryo-injury in human colorectal cancer cells is associated with mitochondrial dysfunction. Int J Cancer. 2001;103:360–9.
Campbell SC, Krishnamurthy V, Chow G, Hale J, Myles J, Novick AC. Renal cryosurgery; experimental evaluation of treatment parameters. Urology. 1998;52:29–34.
Saliken JC, Cohen J, Miller R, et al. Laboratory evaluation of ice formation around a 3-mm accuprobe. Cryobiology. 1995;32:285–95.
Hewitt PM, Zhao J, Akhter J, Morris DL. A comparative laboratory study of liquid nitrogen and argon gas cryosurgery systems. Cryobiology. 1997;35:303–8.
Baissalov R, Sandison GA, Donnelly BJ, et al. A semi-empirical treatment planning model for optimization of multiprobe cryosurgery. Phys Med Biol. 2000;45:1085–98.
Baissalov R, Sandison GA, Reynolds D, Muldrew K. Simultaneous optimization of cryoprobe placement and thermal protocol for cryosurgery. Phys Med Biol. 2001;46:1799–814.
Brewer WH, Austin RS, Capps G, Neifeld JP. Intraoperative monitoring and postoperative imaging of hepatic cryosurgery. Semin Surg Oncol. 1998;14:129–55.
Silverman SG, Sun MR, Tuncali K, et al. Three-dimensional assessment of MRI-guided percutaneous cryotherapy of liver metastases. AJR Am J Roentgenol. 2004;183:707–12.
Silverman SG, Tuncali K, van Sonnenberg E, et al. Renal tumors: MR imaging-guided percutaneous cryotherapy–initial experience in 23 patients. Radiology. 2005;236:716–24.
Tacke J, Speetzen R, Heschel I, et al. Imaging of interstitial cryotherapy – an in vitro comparison of ultrasound, computed tomography, and magnetic resonance imaging. Cryobiology. 1999;38:250–9.
Onik G, Cobb C, Cohen J, et al. US characteristics of frozen prostate. Radiology. 1988;168:629–31.
Anderson JK, Shingleton WB, Cadedda JA. Imaging associated with percutaneous and intraoperative management of renal tumors. Urol Clin North Am. 2006;33:339–52.
Silverman SG, Tuncali K, Adams DF, et al. MR imaging-guided percutaneous cryotherapy of liver tumors: initial experience. Radiology. 2000;217:657–64.
Gupta A, Allaf ME, Kavoussi LR, et al. Computerized tomography guided percutaneous renal cryoablation with the patient under conscious sedation: initial clinical experience. J Urol. 2006;175:447–53.
Permpongkosol S, Sulman A, Solomon SB, et al. Percutaneous computerized tomography guided renal cryoablation using local anesthesia: pain assessment. J Urol. 2006;176:915–8.
Saliken JC, McKinnon JG, Gray R. CT for monitoring cryotherapy. AJR Am J Roentgenol. 1996;166:853–5.
McDannold NJ, Jolesz FA. Magnetic resonance image-guided thermal ablations. Top Magn Reson Imaging. 2000;11(3):191–202.
Mala T, Samset E, Aurdal L, et al. Magnetic resonance imaging-estimated three-dimensional temperature distribution in liver cryolesions; a study of cryolesion characteristics assumed necessary for tumor ablation. Cryobiology. 2001;43:268–75.
Harada J, Dohi M, Magnami T, et al. Initial experience of percutaneous renal cryosurgery under the guidance of a horizontal open MRI system. Radiat Med. 2001;19:291–6.
Mala T, Edwin B, Samset E, Gladhaug I, et al. Magnetic-resonance guided percutaneous cryoablation of hepatic tumours. Eur J Surg. 2001;167:610–7.
Samset E, Mala T, Edwin B, et al. Validation of estimated 3D temperature maps during hepatic cryo surgery. Magn Reson Imaging. 2001;19:715–21.
Mala T. Cryoablation of liver tumors – a review of mechanisms, techniques, and clinical outcome. Minim Invasive Ther Allied Technol. 2006;15:9–17.
Seifert JK, Springer A, Baier P, Junginger T. Liver resection or cryotherapy for colorectal liver metastasis: a prospective case control study. Int J Colorectal Dis. 2005;20:507–20.
Adam R, Hagopian EJ, Linhares M, et al. A comparison of percutaneous cryosurgery and percutaneous radiofrequency for unresectable hepatic malignancies. Arch Surg. 2002;137:1332–9. discussion 1340.
Crews KA, Kuhn JA, McCarty TM, et al. Cryosurgical ablation of hepatic tumors. Am J Surg. 1997;174:614–7. discussion 617–8.
Sarantou T, Bilchik A, Ramming K. Complications of hepatic cryosurgery. Semin Surg Oncol. 1998;14:156–62.
Zhou XD, Tang ZY. Cryotherapy for primary liver cancer. Semin Surg Oncol. 1998;14:171–4.
Permpongkosol S, Nielsen ME, Solomon SB. Percutaneous renal cryoablation. Urology. 2006;68:19–25.
Rodriguez R, Chan DY, Bishoff JT, et al. Renal ablative cryosurgery in selected patients with peripheral renal masses. Urology. 2000;55:25–30.
Hegarty NJ, Gill IS, Desai MM, et al. Probe-ablative nephron-sparing surgery: cryoablation versus radiofrequency ablation. Urology. 2006;68:7–13.
Kaouk JH, Aron M, Rewcastle JC, Gill IS. Cryotherapy: clinical end points and their experimental foundations. Urology. 2006;68:38–44.
Tuncali K, Morrison PR, Tatli S, et al. MRI-guided percutaneous cryoablation of renal tumors: use of external manual displacement of adjacent bowel loops. Eur J Radiol. 2006;59:198–202.
Davol PE, Fulmer BR, Rukstalis DB. Long-term results of cryoablation for renal cancer and complex renal masses. Urology. 2006;68:2–6.
Gill IS, Remer EM, Hasan WA, et al. Renal cryoablation: outcome at 3 years. J Urol. 2005;173:1903–7.
Donnelly BJ, Saliken JC, Ernst DS, et al. Prospective trial of cryosurgical ablation of the prostate: five-year results. Urology. 2002;60:645–8.
Bahn DK, Lee F, Badalament R, et al. Targeted cryoablation of the prostate: 7 year outcomes in the primary treatment of prostate cancer. Urology. 2002;60:3–11.
Chin JL, Downey DB, Mulligan M, Fenster A. Three-dimensional transrectal ultrasound guided cryoablation for localized prostate cancer in nonsurgical candidates: a feasibility study and report of early results. J Urol. 1998;159:910–6.
Cohen JK, Miller Jr RJ, Ahmed S, et al. Ten year biochemical disease control for prostate cancer patients treated with cryosurgery as primary therapy. Urology. 2008;71:515–8.
Mouraviev V, Polascik TJ. Update on cryotherapy for prostate cancer in 2006. Curr Opin Urol. 2006;16:152–6.
Veth R, Schreuder B, van Beem H, et al. Cryosurgery in aggressive, benign, and low-grade malignant bone tumours. Lancet Oncol. 2005;6:25–34.
Callstrom MR, Atwell TD, Charboneau JW, et al. Painful metastases involving bone: percutaneous image-guided cryoablation-prospective trial interim analysis. Radiology. 2006;241(2):572–80.
Callstrom MR, Charboneau JW. Percutaneous ablation: safe, effective treatment of bone tumors. Oncology (Williston Park). 2005;19(11 Suppl 4):22–6.
Wang H, Littrup PJ, Duan Y, Zhang Y, Feng H, Nie Z. Thoracic masses treated with percutaneous cryotherapy: initial experience with more than 200 procedures. Radiology. 2005;235(1):289–98.
Meijer S, de Rooij PD, Derksen EJ, et al. Cryosurgery for locally recurrent rectal cancer. Eur J Surg Oncol. 1992;18:255–7.
Davolos DM, Rubinsky B. Electrical impedence tomography of cell viability in tissue with application to cryosurgery. J Biomech Eng. 2004;126:305–9.
Rossi MR, Tanaka D, Shimada K, Rabin Y. Computerized planning of prostate cryosurgery using variable cryoprobe insertion depth. Cryobiology. 2010;60:71–9.
Yu TH, Liu J, Zhou YX. Selective freezing of target biological tissues after injection of solutions with specific thermal properties. Cryobiology. 2005;50:174–82.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2012 Springer Science+Business Media, LLC
About this chapter
Cite this chapter
Kujala, N., Beland, M.D. (2012). Principles of Cryoablation. In: Mueller, P., Adam, A. (eds) Interventional Oncology. Springer, New York, NY. https://doi.org/10.1007/978-1-4419-1469-9_4
Download citation
DOI: https://doi.org/10.1007/978-1-4419-1469-9_4
Published:
Publisher Name: Springer, New York, NY
Print ISBN: 978-1-4419-1468-2
Online ISBN: 978-1-4419-1469-9
eBook Packages: MedicineMedicine (R0)